By Ahmed Aboulenein
WASHINGTON, April 2 (Reuters) – President Donald Trump signed an executive order on Thursday imposing 100% tariffs on branded pharmaceuticals imported into the U.S. unless manufacturers agree to government drug pricing deals or commit to making their products domestically.
The world’s biggest drugmakers signed deals with the U.S. government last year that exempted billions of dollars of drugs from tariffs. Generic drugs have also been exempted, but small and mid-sized companies are exposed to the penalties unless they craft their own deals or move their production.
Here are some details:
(Reporting by Ahmed Aboulenein; Additional reporting by Ryan Jones; Editing by Caroline Humer, Daniel Wallis, Will Dunham and David Gregorio)
